Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Medical University of Graz
Sponsor:
Information provided by (Responsible Party):
Peter Wolf, MD, Medical University of Graz
ClinicalTrials.gov Identifier:
NCT01088737
First received: March 16, 2010
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)